Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
STRIDES PHARMA SCIENCE TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
STRIDES PHARMA SCIENCE Mar-23 |
TEVA PHARMA Dec-13 |
STRIDES PHARMA SCIENCE/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 392 | 3,484 | - | |
Low | Rs | 263 | 3,027 | - | |
Sales per share (Unadj.) | Rs | 408.5 | 1,999.8 | - | |
Earnings per share (Unadj.) | Rs | -25.6 | 124.9 | - | |
Cash flow per share (Unadj.) | Rs | 1.4 | 286.6 | - | |
Dividends per share (Unadj.) | Rs | 1.50 | 109.36 | - | |
Avg Dividend yield | % | 0.5 | 3.4 | 13.6% | |
Book value per share (Unadj.) | Rs | 242.8 | 2,221.4 | - | |
Shares outstanding (eoy) | m | 90.30 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.8 | 1.6 | 49.3% | |
Avg P/E ratio | x | -12.8 | 26.1 | -49.2% | |
P/CF ratio (eoy) | x | 239.6 | 11.4 | 2,109.4% | |
Price / Book Value ratio | x | 1.4 | 1.5 | 92.1% | |
Dividend payout | % | -5.9 | 87.5 | -6.7% | |
Avg Mkt Cap | Rs m | 29,603 | 2,760,851 | 1.1% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 7,320 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,730.8 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,357.0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 36,884 | 1,695,813 | 2.2% | |
Other income | Rs m | 1,352 | 0 | - | |
Total revenues | Rs m | 38,236 | 1,695,813 | 2.3% | |
Gross profit | Rs m | 830 | 464,399 | 0.2% | |
Depreciation | Rs m | 2,433 | 137,074 | 1.8% | |
Interest | Rs m | 2,611 | 33,309 | 7.8% | |
Profit before tax | Rs m | -2,862 | 294,017 | -1.0% | |
Minority Interest | Rs m | 0 | 1,336 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -193,006 | -0.0% | |
Tax | Rs m | -553 | -3,590 | 15.4% | |
Profit after tax | Rs m | -2,309 | 105,936 | -2.2% | |
Gross profit margin | % | 2.2 | 27.4 | 8.2% | |
Effective tax rate | % | 19.3 | -1.2 | -1,582.6% | |
Net profit margin | % | -6.3 | 6.2 | -100.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 31,353 | 1,145,346 | 2.7% | |
Current liabilities | Rs m | 29,902 | 998,838 | 3.0% | |
Net working cap to sales | % | 3.9 | 8.6 | 45.5% | |
Current ratio | x | 1.0 | 1.1 | 91.4% | |
Inventory Days | Days | 71 | 91 | 78.4% | |
Debtors Days | Days | 129 | 96 | 134.1% | |
Net fixed assets | Rs m | 31,300 | 553,890 | 5.7% | |
Share capital | Rs m | 903 | 4,174 | 21.6% | |
Net worth | Rs m | 21,928 | 1,883,726 | 1.2% | |
Long term debt | Rs m | 11,398 | 867,107 | 1.3% | |
Total assets | Rs m | 63,734 | 3,875,476 | 1.6% | |
Interest coverage | x | -0.1 | 9.8 | -1.0% | |
Debt to equity ratio | x | 0.5 | 0.5 | 112.9% | |
Sales to assets ratio | x | 0.6 | 0.4 | 132.3% | |
Return on assets | % | 0.5 | 3.6 | 13.2% | |
Return on equity | % | -10.5 | 5.6 | -187.2% | |
Return on capital | % | -0.8 | 4.9 | -15.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 444 | 270,225 | 0.2% | |
From Investments | Rs m | 3,025 | -95,752 | -3.2% | |
From Financial Activity | Rs m | -2,139 | -324,153 | 0.7% | |
Net Cashflow | Rs m | 1,328 | -149,680 | -0.9% |
Compare STRIDES PHARMA SCIENCE With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare STRIDES PHARMA SCIENCE With: VILIN BIO MED SHREE GANESH REMEDIES MAKERS LAB. SUDARSHAN PHARMA ALBERT DAVID
After opening the day flat, Indian share markets turned negative as the session progressed and ended lower.